510(k) Report

510(k) · Cleared

Cleared

t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device Updater

K162080510(k) TraditionalCleared Oct 25, 201690-day reviewClass II21 CFR 880.5725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tandem Diabetes Care, Inc. · LZG Pump, Infusion, Insulin

Cleared on Oct 25, 2016 as substantially equivalent to K160482 (Tandem Diabetes Care, Inc., 2016) and 1 other predicate after a 90-day review. Its family tree reaches back 10 generations to 1990. 6 of the 29 devices in its family, counting itself, have a Class I recall.

Decided
Oct 25, 2016
Review
90 days
Class
Class II
Product code
LZG
Recalls
None
Predicates
2

Its longest line of descent runs back 10 generations to K901588 (1990). 28 ancestors in all, the oldest K890120 (1989). No later device cites it as a predicate yet. 6 of the 29 devices in this family, counting this one, have a Class I recall.

  1. Root · 10 generations backK901588 Minimed (R) Model 506 External Insulin PumpMedtronic Minimed · 1990
  2. 6 generations between
  3. 3 generations backK141758 T:Slim Insulin Delivery SystemTandem Diabetes Care, Inc. · 2014
  4. 2 generations backK143189 t:flex Insulin Delivery SystemTandem Diabetes Care, Inc. · 2015
  5. 1 generation backK160482 t:slim Insulin Delivery System, t:flex Insulin Delivery System…Tandem Diabetes Care, Inc. · 2016
  6. This deviceK162080 t:slim Insulin Delivery System, t:flex Insulin Delivery System…Tandem Diabetes Care, Inc. · 2016
Show all 10 generations
  1. Root · 10 generations backK901588 Minimed (R) Model 506 External Insulin PumpMedtronic Minimed · 1990
  2. 9 generations backK960001 Minimed Infusion Pump, Model MMT-507Medtronic Minimed · 1996
  3. 8 generations backK013309 Glucopro Evo Infusion PumpNipro Diabetes Systems, Inc. · 2002 · Recalled
  4. 7 generations backK050312 Amigo Insulin PumpNipro Diabetes Systems, Inc. · 2005
  5. 6 generations backK071613 Amigo Insulin PumpNipro Diabetes Systems, Inc. · 2007
  6. 5 generations backK111210 T:Slim (TM) Insulin Delivery SystemTandem Diabetes Care, Inc. · 2011 · Recalled (Class I)
  7. 4 generations backK133593 T:Slim Insulin Delivery SystemTandem Diabetes Care, Inc. · 2014
  8. 3 generations backK141758 T:Slim Insulin Delivery SystemTandem Diabetes Care, Inc. · 2014
  9. 2 generations backK143189 t:flex Insulin Delivery SystemTandem Diabetes Care, Inc. · 2015
  10. 1 generation backK160482 t:slim Insulin Delivery System, t:flex Insulin Delivery System…Tandem Diabetes Care, Inc. · 2016
  11. This deviceK162080 t:slim Insulin Delivery System, t:flex Insulin Delivery System…Tandem Diabetes Care, Inc. · 2016

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K901588Minimed (R) Model 506 External Insulin PumpMedtronic Minimed1990—
−9K960001Minimed Infusion Pump, Model MMT-507Medtronic Minimed1996—
−8K013309Glucopro Evo Infusion PumpNipro Diabetes Systems, Inc.20021
−7K050312Amigo Insulin PumpNipro Diabetes Systems, Inc.2005—
−6K071613Amigo Insulin PumpNipro Diabetes Systems, Inc.2007—
−5K111210T:Slim (TM) Insulin Delivery SystemTandem Diabetes Care, Inc.2011Class I
−4K133593T:Slim Insulin Delivery SystemTandem Diabetes Care, Inc.2014—
−3K141758T:Slim Insulin Delivery SystemTandem Diabetes Care, Inc.2014—
−2K143189t:flex Insulin Delivery SystemTandem Diabetes Care, Inc.2015—
−1K160482t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device…Tandem Diabetes Care, Inc.2016—
0 (this device)K162080t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device…Tandem Diabetes Care, Inc.2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199010
199110
199410
199510
199610
199710
199810
199921
200211
200310
200422
200510
200610
201111
201610
FIG. 1 — Lineage of K162080, 1990–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

6 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZG device

  1. #1 K253534 Pivot Insulin Delivery Systemscore 16.8 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K160482t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device Updater
Our reading of the summary gave K160428, FDA’s number for Certex Spinal Fixation System (X-Spine Systems, Inc.). Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “Tandem Diabetes Care, Inc. t:slim® Insulin Delivery System, t:flex®…”.
Tandem Diabetes Care, Inc.2016—
*K160056t:slim Insulin Delivery System
Summary page 4
…elivery System, t:flex® Insulin Delivery System, Tandem Device Updater (K160428) Reference Predicate Device: Tandem Diabetes Care, Inc. t:slim® Insulin Delivery System (K160056) Purpose of the 510(k) notification The purpose of this 510(k) is to describe modified indications for use of the t:slim® Insul…
Tandem Diabetes Care, Inc.2016—
†K051264Comfort and Inset Subcutaneous Infusion Sets for Use with Abbott Infusion PumpsUnomedical A/S20051

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (6 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K111386Medfusion Model 4000 Syringe Infusion Pump, Pharmguard Toolbox 2 Medication Safety Software and Supported…Smiths Medical MD, Inc. · 2011 · 2 generations back · ◆ in the 2011 ancestors bar of FIG. 16 Class I recalls
  • K111210T:Slim (TM) Insulin Delivery SystemTandem Diabetes Care, Inc. · 2011 · 3 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K040899Medex 3000 Series MR Syringe Infusion PumpMedex, Inc. · 2004 · 3 generations back · ◆ in the 2004 ancestors bar of FIG. 14 Class I recalls
  • K023264Medley Syringe Pump Module System, Model 8110Alaris Medical Systems, Inc. · 2002 · 3 generations back · ◆ in the 2002 ancestors bar of FIG. 11 Class I recall
  • K990801Minimed 508 Insulin PumpMedtronic Minimed · 1999 · 4 generations back · ◆ in the 1999 ancestors bar of FIG. 11 Class I recall
  • K042873Animas Model IR1250 Insulin Infusion PumpAnimas Corp. · 2004 · 5 generations back · ◆ in the 2004 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 26 years and passes through 3 companies; a new generation was cleared every 2.6 years on median.
  • 13 of the 28 ancestors have a recall of any class; 6 have a Class I recall.

How does its category compare?

All LZG devices

LZG Pump, Infusion, Insulin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · LZG

2in 2024

2007: 32008: 62009: 22010: 22011: 42012: 32013: 22014: 42015: 12016: 42017: 12018: 12019: 22021: 12022: 12023: 12024: 22026 (partial year): 2
2007high 6 (2008) · low 0 (2020)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZG

116in 2016

2007: 112 days median2008: 129 days median2011: 189 days median2012: 73 days median2014: 123 days median2016: 116 days median
2007high 189 (2011) · low 73 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZG

1in 2022

2007: 12008: 132009: 22010: 42011: 22012: 42013: 3, 1 Class I2014: 2, 1 Class I2015: 2, 2 Class I2018: 3, 2 Class I2019: 52022: 1, 1 Class I2026 (partial year): 2, 2 Class I
2007high 13 (2008) · low 0 (2016)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · LZG

12,004in 2025

2007: 5,1102008: 5,7112009: 9,4712010: 10,1752011: 12,8582012: 18,3672013: 30,0592014: 49,1882015: 69,1362016: 56,5812017: 44,4722018: 32,6522019: 29,0272020: 32,5882021: 31,5222022: 28,2252023: 21,9722024: 18,2282025: 12,004
2007high 69,136 (2015) · low 5,110 (2007)2025

MAUDE reports naming product code LZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007311215,110
20086129135,711
20092—29,471
20102—410,175
20114189212,858
2012373418,367
20132—3 (1)30,059
201441232 (1)49,188
20151—2 (2)69,136
20164116056,581
20171—044,472
20181—3 (2)32,652
20192—529,027
20200—032,588
20211—031,522
20221—1 (1)28,225
20231—021,972
20242—018,228
20250—012,004
20262—2 (2)—

What is it indicated for?

The t:slim® Insulin Delivery System is indicated for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin, for individuals 6 years of age and greater. The device is indicated for use with NovoLog® or Humalog® U-100 insulin. The t:flex™ Insulin Delivery System is indicated for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes…

Read the full statement (133 words)

The t:slim® Insulin Delivery System is indicated for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin, for individuals 6 years of age and greater. The device is indicated for use with NovoLog® or Humalog® U-100 insulin.

The t:flex™ Insulin Delivery System is indicated for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin, for individuals 12 years of age and greater. The device is indicated for use with NovoLog® or Humalog® U-100 insulin.

The Tandem® Device Updater™ System consists of software which allows for communication between a computer and a t:slim® or t:flex™ Insulin Delivery System. It allows for remote software installation and update of a Tandem Insulin Delivery System.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K162080: t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device Updater.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162080

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026